Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India

Natco Phrama launched the drug for the treatment of Hepatitis C Virus. It is a fixed combination of Sofosbuvir-Daclatasvir tablets under the brand name of Hepcinat Plus in India.

US FDA gave green signal to Symfi Tablets For The Treatment Of HIV Infection

US FDA gave green signal to Omeprazole and Sodium bicarbonate capsules for the treatment of stomach ailments

FDA Approves Cimduo (lamivudine and tenofovir disoproxil fumarate) Tablets for the Treatment of HIV Infection

FDA Approves Dexycu Intraocular Suspension for the treatment of Postoperative Ocular Inflammation

FDA Approves Scilex Pharmaceuticals’s ZTlido (lidocaine) For The Treatment Of Postherpetic Neuralgia

FDA Approves Vertex’s Symdeko (tezacaftor/ivacaftor) Tablets For The Treatment Of Cystic Fibrosis

U.S. FDA gave green signal to Gilead’s Biktarvy

 FDA approves Erleada Tablets for the treatment of Prostate Cancer

U.S. FDA gave green signal to Advanced Accelerator Application’s Lutathera (lutetium Lu 177 dotatate)

U.S. FDA approved Sanofi-Aventis Admelog (insulin lispro) Injection for the treatment type 1 and type 2 diabetes

U.S. FDA nod for Mylan GmbH’s Ogivri (trastuzumab-dkst) for the treatment of breast and stomach cancer

U.S. FDA approved Merck & Co., Inc.’s Steglujan Tablets for the treatment of Type 2 Diabetes

U.S. FDA has given green signal to Avion Pharmaceuticals, LLC’s Balcotra Tablets

Novartis won U.S. FDA approval for Kisqali (ribociclib) for the treatment of breast cancer

Dynavax received U.S. FDA nod for Heplisav-B [Hepatitis B Vaccine (Recombinant), Adjuvanted]

U.S. FDA approves Bayer drug Aliqopa (copanlisib) for follicular lymphoma

 Drugs approvals hit a new high in 2017